Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Journal of the American Chemical Society called Stereospecific synthesis of cyclobutanol derivatives using a 5 minus 1 methodology and platinum(II), Author is Stewart, Frederick F.; Jennings, P. W., which mentions a compound: 15227-42-6, SMILESS is [Cl-][Pt+2]([N]1=CC=CC=C1)([Cl-])[N]2=CC=CC=C2, Molecular C10H10Cl2N2Pt, SDS of cas: 15227-42-6.
Cycloaddition reaction of the carbene N2CHCO2Et to norbornene in the presence of Rh(II) gave 95% tricyclic esters I (R = CO2Et), which were reduced with LiAlH4 to give 63% I (R = CH2OH) (II). Kinetic resolution of II by oxidative insertion with Pt(py)2Cl2 gave 93% complex III (R = CH2OH) and its isomer, which underwent stereospecific acid-catalyzed ring expansion to give 70-80% complexes IV (R1 = H, Me, CHO; L = py) and their isomers. Ligand substitution with P(OMe)3 gave 100% IV [L = P(OMe)3], which underwent reductive elimination on heating to give 80-90% III (R = OR1).
Although many compounds look similar to this compound(15227-42-6)SDS of cas: 15227-42-6, numerous studies have shown that this compound(SMILES:[Cl-][Pt+2]([N]1=CC=CC=C1)([Cl-])[N]2=CC=CC=C2), has unique advantages. If you want to know more about similar compounds, you can read my other articles.
Reference:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem